116 related articles for article (PubMed ID: 8007745)
1. Uptake and killing of Candida by human peritoneal macrophages and amphotericin B.
Linde HJ; Stille W; Shah PM
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):79-84. PubMed ID: 8007745
[TBL] [Abstract][Full Text] [Related]
2. Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages.
Allwinn R; Schaumann R; Shah PM
Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):163-7. PubMed ID: 8531506
[TBL] [Abstract][Full Text] [Related]
3. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
Chalkley LJ; Trinci AP; Pope AM
Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
[TBL] [Abstract][Full Text] [Related]
4. Effect of amphotericin B alone or in combination with rifampicin on phagocytosis of Candida species by human polymorphonuclear leukocytes.
Schaumann RF; Shah PM
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):753-8. PubMed ID: 1297891
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Nephrol Dial Transplant; 1987; 2(2):104-8. PubMed ID: 3112647
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
9. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
Ponce E; Pechère JC
Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis.
Borg M; Rüchel R
J Med Vet Mycol; 1990; 28(1):3-14. PubMed ID: 2194017
[TBL] [Abstract][Full Text] [Related]
11. Role of macrophages in the candidacidal activity of liposomal amphotericin B.
Mehta RT; Poddar S; Kalidas M; Gomez-Flores R; Dulski K
J Infect Dis; 1997 Jan; 175(1):214-7. PubMed ID: 8985224
[TBL] [Abstract][Full Text] [Related]
12. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
[TBL] [Abstract][Full Text] [Related]
13. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B susceptibility testing of Candida species by flow cytometry.
O'Gorman MR; Hopfer RL
Cytometry; 1991; 12(8):743-7. PubMed ID: 1794254
[TBL] [Abstract][Full Text] [Related]
15. [Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media].
Alp S; Sancak B; Arikan S
Mikrobiyol Bul; 2008 Apr; 42(2):293-300. PubMed ID: 18697427
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
18. A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.
Coste A; Linas MD; Cassaing S; Bernad J; Chalmeton S; Séguéla JP; Pipy B
J Antimicrob Chemother; 2002 May; 49(5):731-40. PubMed ID: 12003965
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
